SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001185185-24-000609
Filing Date
2024-06-04
Accepted
2024-06-04 14:43:18
Documents
15
Period of Report
2024-05-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K novaccess20240604_8k.htm   iXBRL 8-K 23140
2 EXHIBIT 10.1 ex_683436.htm EX-10.1 11663
  Complete submission text file 0001185185-24-000609.txt   170892

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA xsnx-20240531.xsd EX-101.SCH 3229
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xsnx-20240531_def.xml EX-101.DEF 10251
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE xsnx-20240531_lab.xml EX-101.LAB 19158
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xsnx-20240531_pre.xml EX-101.PRE 10560
18 EXTRACTED XBRL INSTANCE DOCUMENT novaccess20240604_8k_htm.xml XML 2649
Mailing Address 8584 E. WASHINGTON STREET, NO. 127 CHAGRIN FALLS OH 44023
Business Address 8584 E. WASHINGTON STREET, NO. 127 CHAGRIN FALLS OH 44023 (213) 642-9268
NovAccess Global Inc. (Filer) CIK: 0001039466 (see all company filings)

IRS No.: 841384159 | State of Incorp.: CO | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-29621 | Film No.: 241017251
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)